Clinical Trials Browser

INDUSTRY × Psoriasis × 1 year × Clear all

Acne Vulgaris, Alopecia, Pressure Ulcer, Dermatitis, Herpes Simplex, Melanoma, Nevus, Psoriasis, Skin Diseases, Tinea, Urticaria, Granuloma Annulare, Keratosis, Seborrheic

NCT07256015 2025-12-01

Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy

Recruiting

200 enrolled

Lymphoid

Lymphoma, Follicular, Psoriasis

NCT03284879 2025-09-08

Post-Marketing Surveillance Study of OTEZLA

Completed

1,086 enrolled

Gastrointestinal

Depression, Gastrointestinal Diseases, Neoplasms, Psoriasis, Vasculitis, Weight Loss, Arthritis, Psoriatic, Suicidal Ideation

NCT05796245 2025-06-04

A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

Completed

2,207 enrolled 10 charts

Arthritis, Rheumatoid, Colitis, Ulcerative, Crohn Disease, Psoriasis

NCT06989216 2025-05-25

DermaFlow

Recruiting

8,000 enrolled

Dermatologic

Dermatitis, Atopic, Psoriasis, Raynaud Disease, Skin Diseases, Skin Neoplasms, Diabetic Foot, Peripheral Arterial Disease

NCT06952465 2025-05-01

A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis

Active not recruiting

2,000 enrolled

Psoriasis

Clinical Trials

LegitHealthSAN

Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy

Post-Marketing Surveillance Study of OTEZLA

A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

DermaFlow

A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis